Strategic Investment NeuroNation Med recently secured a strategic investment from Schwabe Group with advisory by Carlsquare, signaling external validation and potential for scaled partnerships. Use this as a touchpoint to position value in enterprise and clinician-facing solutions.

Clinical Validation Supported by the Ministry of Research and awarded the AOK-Leonardo digital prevention award, NeuroNation demonstrates credible clinical grounding and potential for partnerships with health systems, insurers, and public health programs seeking scalable cognitive health interventions.

Health Tech Fit Technology stack and ISO 13485 certification indicate a focus on compliant, medical-grade digital health products. Target hospitals, clinics, and telehealth platforms that require quality management and regulatory alignment.

Public Health Scale A multi-domain cognitive training platform with over 30 million users shows sizable reach and engagement. Propose partnerships with payers or employers seeking scalable cognitive wellness programs with gamified retention.

Growth and Funding Funding of 7.2 million alongside revenue signals in the low to mid single digits suggests room for expansion in enterprise licenses, B2B partnerships, and international market entry focusing on cognitive health applications for aging populations and mental wellness.